Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
GlobeNewswire, Inc.
BARCELONA, Spain and DÜSSELDORF, Germany, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Neuraxpharm Group and Minoryx Therapeutics today announce that the European Commission (EC) has granted marketing authorisation under exceptional circumstances for...
NV26 Readiness: 352d SOW Integrates with NATO Allies in Iceland
DVIDS - Georgia
AKUREYRI, Iceland – During Exercise Northern Viking 2026, the352d Special Operations Wing worked with Allies and partners from across NATO to validate crucial High North power-projection capabilities.
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
GlobeNewswire, Inc.
Press release – No. 16 / 2026 Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome The CHMP of the European Medicines Agency has recommended the approval of Zeydovio™ (glepaglutide)...
Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day
GlobeNewswire, Inc.
Licaminlimab genotype-based precision medicine approach for TNFR1-mediated dry eye disease in PREDICT-1 registrational symptoms trial on track for topline readout around year-end ZUG, Switzerland, October 7, 2026 -- Oculis Holding AG (Nasdaq: OCS...
Seabees Modernize Airfield Repair on Historical Iceland Footprint
DVIDS - Georgia
Operating under the rainy, cold conditions of the High North, U.S. Navy Seabees assigned to Naval Construction Battalion (NCB) 27 are validating a critical operational capability during exercise Northern Viking 2026 (NV26). Through dedicated...
Defending the “High North”, Exercise Northern Viking 2026 kicks off in Iceland
DVIDS - Georgia
U.S. Air Forces in Europe – Air Forces Africa Airmen and aircraft are joining Icelandic Coast Guard, North Atlantic Treaty Organization forces, and U.S. Joint forces in Iceland for the start of U.S. Sixth Fleet’s Northern Viking 2026 (NV26), Aug....
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
GlobeNewswire, Inc.
REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic...
North America’s Authentic Icelandic Skyr Celebrates Autumn: Icelandic Provisions Launches Pumpkin Spice
EIN Presswire
The Season's Most Beloved Flavor Meets a Thousand Years of Icelandic Tradition, Here for a Limited Time NEW YORK, NY, UNITED STATES, August 19, 2026 /EINPresswire.com/ -- Before fall's first leaf turns and the chill is in the air, Icelandic...
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
GlobeNewswire, Inc.
Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics’ Syracuse facility in New York Strategic long-term partnership to increase Alvotech’s global manufacturing capacity and support growth in demand REYKJAVIK,...
Exercise Northern Viking 2026 Marks 75 Years Of U.S.-Iceland Defense Cooperation
DVIDS - Georgia
U.S. Sailors, Marines, Airmen, and Soldiers have arrived in Keflavik, Iceland, joining forces with the Icelandic Coast Guard and other NATO Allies to officially kick off U.S. Sixth Fleet’s Northern Viking 2026 (NV26) exercise during an opening...
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
GlobeNewswire, Inc.
Approval enables AVT02 drug substance for U.S. commercial supply to be manufactured in either of Alvotech’s two Reykjavik drug substance suites Further confirms resolution of FDA inspection-related matters at the Reykjavik site REYKJAVIK, Iceland,...
Icelandirect Earns SSCI Certification, Strengthening Its Ability to Serve Brands Selling Across Major Retail Channels
GlobeNewswire, Inc.
CLIFTON, N.J., July 09, 2026 (GLOBE NEWSWIRE) -- Icelandirect, LLC, a leading U.S.-based contract manufacturer of supplements, vitamins, and nutraceuticals for human and pet brands, has achieved Supplement Safety & Compliance Initiative (SSCI)...
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
GlobeNewswire, Inc.
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and TANDEM data - - European...
1 Dead in Suspected Russia Plague Case as CDC, US Press Moscow
MENAFN
(MENAFN) U.S. health officials are tracking a suspected case of pneumonic plague in Russia's Irkutsk region that has left one person dead, the Centers for Disease Control and Prevention (CDC) said Tuesday, as Washington pressed Moscow for more...
Icelandirect Achieves FSSC 22000 Certification, Reinforcing Its Commitment to the Highest Standards in Supplement Manufacturing
GlobeNewswire, Inc.
CLIFTON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Icelandirect, LLC, a leading U.S.-based contract manufacturer of supplements, vitamins, and nutraceuticals for both human and pet brands, is pleased to announce the successful completion of its FSSC...
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
GlobeNewswire, Inc.
BRUSSELS, July 01, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced that it has completed the acquisition of exclusive development and...
High Levels of Trust Elevate the Fortune 100 Best Companies to Work For, Europe in 2026
GlobeNewswire, Inc.
Oakland, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Great Place To Work® and Fortune Europe announce the 2026 Fortune 100 Best Companies to Work For™ Europe, highlighting the best employers, regardless of industry or country of origin.
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
GlobeNewswire, Inc.
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in...
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
GlobeNewswire, Inc.
PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DED This FDA-aligned trial targets the specific TNFR1 genotype to maximize...
Oculis Announces Resignation of Lionel Carnot from Board of Directors
GlobeNewswire, Inc.
Oculis Announces Resignation of Lionel Carnot from Board of Directors ZUG, Switzerland, September 30, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough...
Sign up for:
Iceland Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.